BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27711089)

  • 1. Serenoa repens associated with selenium and lycopene extract and bromelain and methylsulfonylmethane extract are able to improve the efficacy of levofloxacin in chronic bacterial prostatitis patients.
    Cai T; Tiscione D; Gallelli L; Verze P; Palmieri A; Mirone V; Bartoletti R; Malossini G
    Arch Ital Urol Androl; 2016 Oct; 88(3):177-182. PubMed ID: 27711089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic prostatitis/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study.
    Morgia G; Mucciardi G; Galì A; Madonia M; Marchese F; Di Benedetto A; Romano G; Bonvissuto G; Castelli T; Macchione L; Magno C
    Urol Int; 2010; 84(4):400-6. PubMed ID: 20332612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study.
    Cai T; Mazzoli S; Bechi A; Addonisio P; Mondaini N; Pagliai RC; Bartoletti R
    Int J Antimicrob Agents; 2009 Jun; 33(6):549-53. PubMed ID: 19181486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flower Pollen Extract in Association with Vitamins (Deprox 500®) Versus Serenoa repens in Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Comparative Analysis of Two Different Treatments.
    Macchione N; Bernardini P; Piacentini I; Mangiarotti B; Del Nero A
    Antiinflamm Antiallergy Agents Med Chem; 2019; 18(2):151-161. PubMed ID: 30488800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness on urinary symptoms and erectile function of Prostamev Plus® vs only extract Serenoa repens.
    Marzano R; Dinelli N; Ales V; Bertozzi MA
    Arch Ital Urol Androl; 2015 Mar; 87(1):25-7. PubMed ID: 25847892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Serenoa repens, selenium and lycopene (Profluss®) on chronic inflammation associated with benign prostatic hyperplasia: results of "FLOG" (Flogosis and Profluss in Prostatic and Genital Disease), a multicentre Italian study.
    Morgia G; Cimino S; Favilla V; Russo GI; Squadrito F; Mucciardi G; Masieri L; Minutoli L; Grosso G; Castelli T
    Int Braz J Urol; 2013; 39(2):214-21. PubMed ID: 23683667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicentre study on the efficacy and tolerability of an extract of Serenoa repens in patients with chronic benign prostate conditions associated with inflammation.
    Giulianelli R; Pecoraro S; Sepe G; Leonardi R; Gentile BC; Albanesi L; Brunori S; Mavilla L; Pisanti F; Giannella R; Morello P; Tuzzolo D; Coscione M; Galasso F; D'Angelo T; Ferravante P; Morelli E; Miragliuolo A;
    Arch Ital Urol Androl; 2012 Jun; 84(2):94-8. PubMed ID: 22908779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levofloxacin for NIH Category II Chronic Bacterial Prostatitis: A Real-Life Study.
    Magri V; Perletti G; Cai T; Stamatiou K; Trinchieri A; Montanari E
    Chemotherapy; 2019; 64(1):8-16. PubMed ID: 31112957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic bacterial prostatitis: efficacy of short-lasting antibiotic therapy with prulifloxacin (Unidrox®) in association with saw palmetto extract, lactobacillus sporogens and arbutin (Lactorepens®).
    Busetto GM; Giovannone R; Ferro M; Tricarico S; Del Giudice F; Matei DV; De Cobelli O; Gentile V; De Berardinis E
    BMC Urol; 2014 Jul; 14():53. PubMed ID: 25038794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome.
    Wang J; Yan D; Liang K; Xu Z
    Int Urol Nephrol; 2016 Jan; 48(1):13-8. PubMed ID: 26577998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serenoa repens, lycopene and selenium versus tamsulosin for the treatment of LUTS/BPH. An Italian multicenter double-blinded randomized study between single or combination therapy (PROCOMB trial).
    Morgia G; Russo GI; Voce S; Palmieri F; Gentile M; Giannantoni A; Blefari F; Carini M; Minervini A; Ginepri A; Salvia G; Vespasiani G; Santelli G; Cimino S; Allegro R; Collura Z; Fragalà E; Arnone S; Pareo RM
    Prostate; 2014 Nov; 74(15):1471-80. PubMed ID: 25154739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of an association of palmitoylethanolamide and alpha-lipoic acid in patients with chronic prostatitis/chronic pelvic pain syndrome: A randomized clinical trial.
    Giammusso B; Di Mauro R; Bernardini R
    Arch Ital Urol Androl; 2017 Mar; 89(1):17-21. PubMed ID: 28403589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serenoa repens extract additionally to quinolones in the treatment of chronic bacterial prostatitis. The preliminary results of a long term observational study.
    Stamatiou K; Pierris N
    Arch Ital Urol Androl; 2013 Dec; 85(4):190-6. PubMed ID: 24399120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pollen extract in association with vitamins (DEPROX 500®) for pain relief in patients affected by chronic prostatitis/chronic pelvic pain syndrome: results from a pilot study.
    Cai T; Luciani LG; Caola I; Mondaini N; Malossini G; Lanzafame P; Mazzoli S; Bartoletti R
    Urologia; 2013 Apr; 80 Suppl 22():5-10. PubMed ID: 23334883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Use of a Combination of Vaccinium Macracarpon, Lycium barbarum L. and Probiotics (Bifiprost®) for the Prevention of Chronic Bacterial Prostatitis: A Double-Blind Randomized Study.
    Chiancone F; Carrino M; Meccariello C; Pucci L; Fedelini M; Fedelini P
    Urol Int; 2019; 103(4):423-426. PubMed ID: 31527377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of levofloxacin 750 mg for 2 weeks or 3 weeks compared with levofloxacin 500 mg for 4 weeks in treating chronic bacterial prostatitis.
    Paglia M; Peterson J; Fisher AC; Qin Z; Nicholson SC; Kahn JB
    Curr Med Res Opin; 2010 Jun; 26(6):1433-41. PubMed ID: 20394471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of Proxelan in the treatment of chronic prostatitis. Results of a randomized trial].
    Galeone G; Spadavecchia R; Balducci MT; Pagliarulo V
    Minerva Urol Nefrol; 2012 Jun; 64(2):135-41. PubMed ID: 22617307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fosfomycin trometamol and N-acetyl-L-cysteine as combined oral therapy of difficult-to-treat chronic bacterial prostatitis: Results of a pilot study.
    Cai T; Tamanini I; Mattevi D; Verze P; Palmieri A; Malossini G; Mirone V; Novelli A; Tascini C; Johansen TEB
    Int J Antimicrob Agents; 2020 Jul; 56(1):105935. PubMed ID: 32156620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia.
    Russo A; Capogrosso P; La Croce G; Ventimiglia E; Boeri L; Briganti A; Damiano R; Montorsi F; Salonia A
    Expert Opin Drug Saf; 2016 Dec; 15(12):1661-1670. PubMed ID: 27232207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Approaches to raising efficacy of treatment of patients with chronic prostatitis associated with intracellular infections].
    Kul'chavenia EV; Breusov AA; Brizhatiuk EV; Kholtobin DP
    Urologiia; 2010; (6):55-8. PubMed ID: 21427997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.